These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8957249)

  • 1. Omega-agatoxin IVA blocks spinal morphine/clonidine antinociceptive synergism.
    Roerig SC; Howse KM
    Eur J Pharmacol; 1996 Oct; 314(3):293-300. PubMed ID: 8957249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal morphine/clonidine antinociceptive synergism: involvement of G proteins and N-type voltage-dependent calcium channels.
    Wei ZY; Karim F; Roerig SC
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1392-407. PubMed ID: 8819527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinally delivered N-, P/Q- and L-type Ca2+-channel blockers potentiate morphine analgesia in mice.
    Fukuizumi T; Ohkubo T; Kitamura K
    Life Sci; 2003 Oct; 73(22):2873-81. PubMed ID: 14511772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased spinal morphine/clonidine antinociceptive synergism in morphine-tolerant mice.
    Roerig SC
    Life Sci; 1995; 56(5):PL115-22. PubMed ID: 7837926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of omega-agatoxin IVA, a P-type calcium channel antagonist, on the development of spinal neuronal hyperexcitability caused by knee inflammation in rats.
    Nebe J; Ebersberger A; Vanegas H; Schaible HG
    J Neurophysiol; 1999 Jun; 81(6):2620-6. PubMed ID: 10368382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of spinal protein kinase C expression and kinetics in morphine, but not clonidine, tolerance.
    Li Y; Roerig SC
    Biochem Pharmacol; 1999 Aug; 58(3):493-501. PubMed ID: 10424770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of acetylcholine release from mouse motor nerve by a P-type calcium channel blocker, omega-agatoxin IVA.
    Hong SJ; Chang CC
    J Physiol; 1995 Jan; 482 ( Pt 2)(Pt 2):283-90. PubMed ID: 7714822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal morphine/clonidine antinociceptive synergism is regulated by protein kinase C, but not protein kinase A activity.
    Wei ZY; Roerig SC
    J Pharmacol Exp Ther; 1998 Dec; 287(3):937-43. PubMed ID: 9864276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure changes after intrathecal co-administration of calcium channel blockers with morphine or clonidine at the spinal level.
    Horvath G; Brodacz B; Holzer-Petsche U
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Sep; 366(3):270-5. PubMed ID: 12172710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of invertebrate peptide toxins to establish Ca2+ channel identity of CA3-CA1 neurotransmission in rat hippocampal slices.
    Nooney JM; Lodge D
    Eur J Pharmacol; 1996 Jun; 306(1-3):41-50. PubMed ID: 8813613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal antinociceptive synergism between morphine and clonidine persists in mice made acutely or chronically tolerant to morphine.
    Fairbanks CA; Wilcox GL
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1107-16. PubMed ID: 10027848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydropyridine block of omega-agatoxin IVA- and omega-conotoxin GVIA-sensitive Ca2+ channels in rat pituitary melanotropic cells.
    Mansvelder HD; Stoof JC; Kits KS
    Eur J Pharmacol; 1996 Sep; 311(2-3):293-304. PubMed ID: 8891612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nonpeptide alpha-eudexp6l from Juniperus virginiana Linn. (Cupressaceae) inhibits omega-agatoxin IVA-sensitive Ca2+ currents and synaptosomal 45Ca2+ uptake.
    Asakura K; Kanemasa T; Minagawa K; Kagawa K; Ninomiya M
    Brain Res; 1999 Mar; 823(1-2):169-76. PubMed ID: 10095023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal antinociceptive action of an N-Type voltage-dependent calcium channel blocker and the synergistic interaction with morphine.
    Omote K; Kawamata M; Satoh O; Iwasaki H; Namiki A
    Anesthesiology; 1996 Mar; 84(3):636-43. PubMed ID: 8659792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of omega-agatoxin-IVA on autonomic neurotransmission.
    Lundy PM; Frew R
    Eur J Pharmacol; 1994 Aug; 261(1-2):79-84. PubMed ID: 8001657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of N-, P- and Q-type neuronal calcium channel antagonists on mammalian peripheral neurotransmission.
    Wright CE; Angus JA
    Br J Pharmacol; 1996 Sep; 119(1):49-56. PubMed ID: 8872356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in L-type calcium channels in the brain and spinal cord of acutely treated and morphine-tolerant mice.
    Bernstein MA; Welch SP
    Brain Res; 1995 Oct; 696(1-2):83-8. PubMed ID: 8574689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment with pertussis toxin blocks morphine- but not beta-endorphin-induced antinociception in the mouse.
    Tseng LF; Collins KA
    Eur J Pharmacol; 1995 Dec; 294(1):345-8. PubMed ID: 8788451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial distribution of omega-agatoxin IVA binding sites in mouse brain slices.
    Nakanishi S; Fujii A; Kimura T; Sakakibara S; Mikoshiba K
    J Neurosci Res; 1995 Jul; 41(4):532-9. PubMed ID: 7473885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. omega-Agatoxin IVA blocks nicotinic receptor channels in bovine chromaffin cells.
    Granja R; Fernández-Fernández JM; Izaguirre V; González-García C; Ceña V
    FEBS Lett; 1995 Mar; 362(1):15-8. PubMed ID: 7698345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.